| European Case Law Identifier: | ECLI:EP:BA:2015:T216811.20150624 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 24 June 2015 | ||||||||
| Case number: | T 2168/11 | ||||||||
| Application number: | 94931891.9 | ||||||||
| IPC class: | C12N 15/00 C12N 15/12 C07K 14/47 A01K 67/027 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | TRANSGENIC ANIMALS HARBORING APP ALLELE HAVING SWEDISH MUTATION | ||||||||
| Applicant name: | ELAN PHARMACEUTICALS, INC. ELI LILLY AND COMPANY |
||||||||
| Opponent name: | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft GLAXO GROUP LIMITED Bayer AG |
||||||||
| Board: | 3.3.08 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | "Main Request - inventive step (no)" "Admissibility of first, second and third Auxiliary Requests into the appeal proceedings (no)" |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t112168eu1.html
Date retrieved: 17 May 2021